Health & Medicine

July 16, 2013

FDA gives green light to SynGen for cord blood-processing products

Buoyed by another round of multimillion-dollar financing, Sacramento-based startup SynGen Inc. has cleared a significant federal hurdle to get its cord blood-processing products on the market.

Related content

Comments

 

Videos

Editor's Choice Videos